Literature DB >> 21964706

Mechanism of arterial remodeling in chronic allograft vasculopathy.

Qichang Zheng1, Shanglong Liu, Zifang Song.   

Abstract

Chronic allograft vasculopathy (CAV) remains a major obstacle for long-term survival of grafts even though therapeutic strategies have improved considerably in recent years. CAV is characterized by concentric and diffuse neointimal formation, medial apoptosis, infiltration of lymphocyte or inflammatory cells, and deposition of extracellular matrix both in arteries and veins. Recent studies have shown that stem cells derived from the recipient contribute to neointimal formation under the regulation of chemokines and cytokines. Arterial remodeling in allografts eventually causes ischemic graft failure. The pathogenesis is multi-factorial with both immunologic and non-immunological factors being involved. The immunological factors have been discussed extensively in other articles. This review focuses mainly on the arterial remodeling that occurs in 3 layers of vessel walls including intimal injury, accumulation of smooth muscle-like cells in the neointimal, medial smooth muscle cell apoptosis, adventitial fibrosis, and deposition of extracellular matrix.

Entities:  

Mesh:

Year:  2011        PMID: 21964706     DOI: 10.1007/s11684-011-0149-3

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  55 in total

Review 1.  Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant.

Authors:  S Sartore; A Chiavegato; E Faggin; R Franch; M Puato; S Ausoni; P Pauletto
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

Review 2.  Pathogenesis of chronic allograft rejection.

Authors:  Simone A Joosten; Cees van Kooten; Leendert C Paul
Journal:  Transpl Int       Date:  2003-02-25       Impact factor: 3.782

3.  Homing of Mesenchymal Stem Cells.

Authors:  Reinhard Henschler; Erika Deak; Erhard Seifried
Journal:  Transfus Med Hemother       Date:  2008-07-21       Impact factor: 3.747

Review 4.  Vascular disease: a new progenitor biology.

Authors:  Pat Metharom; Noel M Caplice
Journal:  Curr Vasc Pharmacol       Date:  2007-01       Impact factor: 2.719

Review 5.  Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy.

Authors:  M R Mehra
Journal:  Am J Transplant       Date:  2006-06       Impact factor: 8.086

6.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.

Authors:  Masataka Sata; Akio Saiura; Atsushi Kunisato; Akihiro Tojo; Seiji Okada; Takeshi Tokuhisa; Hisamaru Hirai; Masatoshi Makuuchi; Yasunobu Hirata; Ryozo Nagai
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

7.  Immunologic targets in the etiology of allograft vasculopathy: endothelium versus media.

Authors:  Maria Currie; Amr M Zaki; Sara Nejat; Gregory M Hirsch; Timothy D G Lee
Journal:  Transpl Immunol       Date:  2008-04-11       Impact factor: 1.708

8.  The origin of neointimal smooth muscle cells in transplant arteriosclerosis from recipient bone-marrow cells in rat aortic allograft.

Authors:  Zifang Song; Wei Li; Qichang Zheng; Dan Shang; Xiaogang Shu; Siming Guan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-06

Review 9.  ICAM-1 signaling in endothelial cells.

Authors:  Charlotte Lawson; Sabine Wolf
Journal:  Pharmacol Rep       Date:  2009 Jan-Feb       Impact factor: 3.024

10.  Host-derived smooth muscle cells accumulate in cardiac allografts: role of inflammation and monocyte chemoattractant protein 1.

Authors:  Piotr Religa; Monika K Grudzinska; Krzysztof Bojakowski; Joanna Soin; Jerzy Nozynski; Michal Zakliczynski; Zbigniew Gaciong; Marian Zembala; Cecilia Söderberg-Nauclér
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

View more
  5 in total

Review 1.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

2.  Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.

Authors:  Maria Nurminskaya; Kelly E Beazley; Elizabeth P Smith; Alexey M Belkin
Journal:  J Vasc Res       Date:  2015-01-22       Impact factor: 1.934

3.  Characteristics of cardiac allograft vasculopathy induced by immunomodulation in the miniature Swine.

Authors:  Jun Amano; Tomohiro Akashima; Takamitsu Terasaki; Yuko Wada; Midori Ito-Amano; Jun-Ichi Suzuki; Mitsuaki Isobe
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-04-18       Impact factor: 1.520

4.  A reproducible mouse model of chronic allograft nephropathy with vasculopathy.

Authors:  Abolfazl Zarjou; Lingling Guo; Paul W Sanders; Roslyn B Mannon; Anupam Agarwal; James F George
Journal:  Kidney Int       Date:  2012-08-08       Impact factor: 10.612

Review 5.  Failing Heart Transplants and Rejection-A Cellular Perspective.

Authors:  Maria Hurskainen; Olli Ainasoja; Karl B Lemström
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.